Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Net Margin of 16.47% in Q4 2025, up 6.98% quarter-over-quarter from 15.4% in Q3 2025, and down 455.0% on a YoY basis from 4.64% in Q4 2024.
Prestige Consumer Healthcare (PBH) Net Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Net Margin history runs 16 years deep, the most recent figure standing at 16.47% for Q4 2025.
- In Q4 2025, Net Margin fell 455.0% year-over-year to 16.47%; the TTM figure through Dec 2025 stood at 16.9% (down 223.0% YoY), while the FY2025 annual figure was 18.86%, up 26.0% from the prior year.
- Net Margin was 16.47% for Q4 2025 at Prestige Consumer Healthcare, up from 15.4% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 21.46% in Q2 2021 to a low of 84.15% in Q1 2023.
- Historically, Net Margin has averaged 13.18% across 5 years, with a median of 18.54% in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Margin slumped 10366 bps in 2023, then soared 10200 bps in 2024.
- A 5-year view of Net Margin shows it stood at 18.3% in 2021, then increased by 3 bps to 18.86% in 2022, then slipped by 0 bps to 18.76% in 2023, then rose by 12 bps to 21.02% in 2024, then slipped by 22 bps to 16.47% in 2025.
- The last three Net Margin figures came in at 16.47% (Q4 2025), 15.4% (Q3 2025), and 19.02% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -168.42% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.15% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 31.38% |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 16.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.47% |
| Sep 30, 2025 | 15.40% |
| Jun 30, 2025 | 19.02% |
| Mar 31, 2025 | 16.91% |
| Dec 31, 2024 | 21.02% |
| Sep 30, 2024 | 19.16% |
| Jun 30, 2024 | 18.37% |
| Mar 31, 2024 | 17.86% |
| Dec 31, 2023 | 18.76% |
| Sep 30, 2023 | 18.71% |
| Jun 30, 2023 | 19.07% |
| Mar 31, 2023 | -84.15% |
| Dec 31, 2022 | 18.86% |
| Sep 30, 2022 | 17.64% |
| Jun 30, 2022 | 19.95% |
| Mar 31, 2022 | 19.51% |
| Dec 31, 2021 | 18.30% |
| Sep 30, 2021 | 16.41% |
| Jun 30, 2021 | 21.46% |
| Mar 31, 2021 | 14.94% |